Biotech Bonanza: 2023 Biotech Outlook As The Fed Remains Hawkish

Federal Reserve interest rate policy to again remain the market focus this year and create a chaotic first half. Biotechnology should be favorably positioned relative to the market if the economy slips into a recession. Biotech fortunes near term are to be determined by the performance of the 10-year yield, which should likely remain anchored or slip due to economic concerns.

Continue reading

Europe’s ESG ETF industry proves resilient

Morningstar notes that one of the most significant flow trends during 2022 was investors’ continued support for ESG-tailored ETFs which gathered €51bn net new assets, despite these strategies underperforming more mainstream exposures over the year. According to BI’s Global Asset

Continue reading

USCF Launches Sustainable Battery Metals Strategy Fund

USCF today announced it has launched the USCF Sustainable Battery Metals Strategy Fund (NYSE Arca: ZSB), which seeks total return by investing primarily in metals derivative instruments and, to a lesser extent, the equity securities of companies that are economically tied to the metals that are necessary for the process known as “electrification.”

Continue reading

1 10 11 12 13 14 25